|
End-of-day quote
Korea S.E.
2026-10-22
|
5-day change | 1st Jan Change | ||
| 194,300.00 KRW | -1.67% |
|
+6.70% | +12.72% |
| 12:50am | SK Securities Adjusts Celltrion's Price Target to 280,000 Won | MT |
| 10-22 | Celltrion Signs License-In Deal With Kaigene for KG013 Immune-Mediated Disease Drug Candidate | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 33.45B | |||||
| 63.29B | |||||
| 54.89B | |||||
| 53.28B | |||||
| 45.81B | |||||
| 43.46B |
- Stock Market
- Stocks
- A068270 Stock
- Charts Celltrion, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
